NASDAQ$GOCO

GoHealth Inc · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

GoHealth's Q4 2020 earnings were released, showcasing substantial revenue growth and strategic investments for future expansion.

GoHealth reported a strong fourth quarter with a 55% increase in net revenue, driven by a 75% revenue growth in the Internal Medicare segment. The company is focused on investing in its platform to drive commissionable revenue growth and sustain long-term growth.

  • Net revenue for Q4 2020 increased by 55% year-over-year, reaching $445.9 million.
  • Medicare Advantage (MA) Submitted Policies grew by 58% compared to the prior year, totaling 330,604.
  • LTV per carrier Approved MA Submission increased by 5% to $1,073.
  • Net income for Q4 2020 was $133.1 million.

Headline financials

Total Revenue

$446M

Previous: $308M+44.5%
EPS (adj)

$6.15

Previous: $0.77+703.9%
Sales per Submission

$1.07K

Previous: $1.02K+5.3%
Net Income

$133M

Previous: $16M+732.1%
Operating Income

$142M

Previous: $24.1M+488.6%
Gross Profit

$351M

Previous: $218M+61.0%
Cash & Equivalents

$144M

No prior period
Total Assets

$2.11B

No prior period
Stock-Based Comp

$3.08M

No prior period

Revenue & EPS history

GoHealth · Revenue · Quarterly

$446M

Q4 2020+44.5%vs Q4 2019
Beat estimate in 7 of 12 quarters(58%)
ActualEstimate

Revenue by segment

GoHealth · $11.9M total across 4 segments · Q1 2026

  • Medicare Agency Revenue
    $9.8M
  • Other Non-Agency Revenue
    $1.76M
  • Medicare Non-Agency Revenue
    $200K
  • Other Agency Revenue
    $155K

Forward guidance

The Company provided its full year 2021 outlook, and expects total net revenue of $1,150 - $1,300 million (+31% to +48%) powered by commission revenue of $950 - $1,100 million (+42% to +64%). The company also expects adjusted EBITDA of $345 - $385 million (+27% to +42%)

Tailwinds

  • Full-year 2021 net revenue of $1,150 - $1,300 million, representing year-over-year growth of 31% - 48%
  • Full-year 2021 commission revenue of $950 - $1,100 million, representing year-over-year growth of 42% - 64%, fueled by the Company’s continued investment in its Medicare business
  • Full-year 2021 adjusted EBITDA of $345 - $385 million, representing year-over-year growth of 27% - 42%
  • Favorable long-term industry dynamics for technology-driven, direct-to-consumer models
  • Strong consumer demand for services, particularly around education, transparency and choice

Headwinds

  • Trajectory of the US economy remains challenging to predict
  • Continued uncertainty associated with the pace of recovery from the COVID-19 pandemic.
  • Potential for an adverse change in the Company’s relationships with carriers, including a loss of a carrier relationships
  • Failure to grow the Company’s customer base or retain its existing customers
  • Carriers’ ability to reduce commissions paid to the Company and adversely change their underwriting practices

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-7.7%

Avg return

Earnings day

-9.7%

Avg return

5 days after

-6.6%

Avg return

30 days after

26%

6 / 23 earnings

Positive

+32.2%

Q1 2023

Best reaction

-45.5%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.5%-23.4%
Q3 2025-24.4%-32.0%-12.8%
Q2 2025-9.0%-7.6%-23.8%
Q1 2025-0.6%-17.4%-21.4%
Q4 2024-14.4%-14.9%-32.8%
Q3 2024-6.6%-0.4%-15.4%
Q2 2024-21.4%-28.3%-34.0%
Q1 2024-8.0%-11.1%+2.2%
Q4 2023-13.0%-25.7%-27.0%
Q3 2023+2.3%+6.7%+7.4%
Q2 2023+6.8%+6.3%-17.2%
Q1 2023+32.2%+44.8%+99.5%
Q4 2022-19.9%-6.2%-18.5%
Q3 2022-16.7%-9.4%+95.3%
Q2 2022-31.5%-43.3%-57.0%
Q1 2022+11.1%+4.9%+6.5%
Q4 2021+23.7%+37.7%-9.8%
Q3 2021+1.1%-4.7%-18.1%
Q2 2021-45.5%-42.2%-34.7%
Q1 2021-2.7%-5.6%-4.0%
Q4 2020-14.9%-16.9%-4.1%
Q3 2020-14.9%-15.1%+1.8%
Q2 2020-10.5%-18.5%-27.1%
Q1 2020
Q4 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro